tirzepatide weight loss percentage reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 Tirzepatide | Nudge Fit |

Tirzepatide is a dual GIP and GLP-1 receptor agonist that works by regulating appetite, slowing gastric emptying, and improving insulin sensitivity

The most significant weight reduction often occurs around the 6-month mark, and in many cases, progress continues for up to a year or longer when paired with a healthy diet and regular physical activity

The folate blood test evaluates the levels of folic acid (vitamin B9) in the blood, an essential nutrient for the formation of red blood cells and DNA synthesis

We provide full video guidance and clinical support to help you feel confident from day one

Whilst semaglutide has demonstrated cardiovascular benefits in clinical trials for people with type 2 diabetes, the interaction between these opposing cardiovascular profiles is not well studied